Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Experimental cancer drugs
OSI-7904
Другие языки:

    OSI-7904

    Подписчиков: 0, рейтинг: 0
    OSI-7904
    OSI-7904.svg
    Legal status
    Legal status
    • Investigational
    Identifiers
    • (2S)-2-[6-[(3-Methyl-1-oxo-2H-benzo[f]quinazolin-9-yl)methylamino]-3-oxo-1H-isoindol-2-yl]pentanedioic acid
    CAS Number
    PubChem CID
    UNII
    CompTox Dashboard (EPA)
    Chemical and physical data
    Formula C27H24N4O6
    Molar mass 500.511 g·mol−1
    3D model (JSmol)
    • CC1=NC2=C(C3=C(C=CC(=C3)CNC4=CC5=C(C=C4)C(=O)N(C5)[C@@H](CCC(=O)O)C(=O)O)C=C2)C(=O)N1

    OSI-7904 is a noncompetitive liposomal thymidylate synthase inhibitor. OSI-7904 is a benzoquinazoline folate analog with antineoplastic activity. As a thymidylate synthase inhibitor, OSI-7904 noncompetitively binds to thymidylate synthase, resulting in inhibition of thymine nucleotide synthesis and DNA replication.

    OSI-7904L is a liposome-encapsulated formulation of OSI-7904. Liposome encapsulation improves the efficacy and increases the half-life of OSI-7904.

    Its effect on solid tumors is currently under evaluation.



    Новое сообщение